SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venmax Drugs & Pharmaceuticals informs about newspaper advertisement

10 Feb 2025 Evaluate

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Venmax Drugs & Pharmaceuticals has informed that it enclosed copies of the newspaper advertisement of the financial results for the Quarter and Nine Months ended December 31, 2024 published in ‘Financial Express’ and ‘Nava Telangana’ on 09.02.2025. The same has been available on the Company’s website at www.venmaxdrugs.com.

The above information is a part of company’s filings submitted to BSE.

Venmax Drugs&Pharma Share Price

24.66 1.07 (4.54%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×